Global Fibrinogen Market Growth 2025-2031

The global Fibrinogen market size is predicted to grow from US$ 1034 million in 2025 to US$ 2502 million in 2031; it is expected to grow at a CAGR of 15.9% from 2025 to 2031.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

LP Information, Inc. (LPI) ' newest research report, the “Fibrinogen Industry Forecast” looks at past sales and reviews total world Fibrinogen sales in 2024, providing a comprehensive analysis by region and market sector of projected Fibrinogen sales for 2025 through 2031. With Fibrinogen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fibrinogen industry.

This Insight Report provides a comprehensive analysis of the global Fibrinogen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fibrinogen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fibrinogen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fibrinogen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fibrinogen.

This report presents a comprehensive overview, market shares, and growth opportunities of Fibrinogen market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Human Fibrinogen
Animal Fibrinogen

Segmentation by Application:
Congenital Fibrinogen Deficiency
Surgical Procedures
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Taibang Biologic
Octapharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fibrinogen market?

What factors are driving Fibrinogen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fibrinogen market opportunities vary by end market size?

How does Fibrinogen break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.